145 related articles for article (PubMed ID: 14600138)
21. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae.
Kerr JR; Barah F; Chiswick ML; McDonnell GV; Smith J; Chapman MD; Bingham JB; Kelleher P; Sheppard MN
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):739-46. PubMed ID: 12438480
[TBL] [Abstract][Full Text] [Related]
22. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.
Nigro G; Bastianon V; Colloridi V; Ventriglia F; Gallo P; D'Amati G; Koch WC; Adler SP
Clin Infect Dis; 2000 Jul; 31(1):65-9. PubMed ID: 10913398
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
24. Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles.
Kerr JR; Mattey DL; Thomson W; Poulton KV; Ollier WE
J Infect Dis; 2002 Aug; 186(4):447-52. PubMed ID: 12195370
[TBL] [Abstract][Full Text] [Related]
25. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
26. Preexisting psychological stress predicts acute and chronic fatigue and arthritis following symptomatic parvovirus B19 infection.
Kerr JR; Mattey DL
Clin Infect Dis; 2008 May; 46(9):e83-7. PubMed ID: 18419428
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.
Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y
J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609
[TBL] [Abstract][Full Text] [Related]
28. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
29. Cytopenia caused by parvovirus in an adult ALL patient.
De Renzo A; Azzi A; Zakrzewska K; Cicoira L; Notaro R; Rotoli B
Haematologica; 1994; 79(3):259-61. PubMed ID: 7926975
[TBL] [Abstract][Full Text] [Related]
30. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.
Oğuz F; Akdeniz C; Unüvar E; Küçükbasmaci O; Sidal M
J Paediatr Child Health; 2002 Aug; 38(4):358-62. PubMed ID: 12173996
[TBL] [Abstract][Full Text] [Related]
31. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
32. Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders.
Jitschin R; Peters O; Plentz A; Turowski P; Segerer H; Modrow S
Clin Microbiol Infect; 2011 Sep; 17(9):1336-42. PubMed ID: 20825443
[TBL] [Abstract][Full Text] [Related]
33. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
Corcoran A; Crowley B; Dewhurst C; Pizer BL; Doyle S
J Med Virol; 2006 Jan; 78(1):125-8. PubMed ID: 16299723
[TBL] [Abstract][Full Text] [Related]
34. Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia.
Zaki ME; Ashray RE
Int J Lab Hematol; 2010 Apr; 32(2):159-66. PubMed ID: 19261033
[TBL] [Abstract][Full Text] [Related]
35. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities.
da Costa AC; Bendit I; de Oliveira ACS; Kallas EG; Sabino EC; Sanabani SS
Clin Microbiol Infect; 2013 Jan; 19(1):E31-E43. PubMed ID: 23167493
[TBL] [Abstract][Full Text] [Related]
36. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
37. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus infection in a child with acute lymphoblastic leukemia.
Alberti M; Fiori GM; Sanna MA
Haematologica; 1999 Jan; 84(1):85. PubMed ID: 10091396
[No Abstract] [Full Text] [Related]
40. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
